NCT03333109 - Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients | Biotech Hunter

Enrollment

900

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

January 13, 2020

Study Completion Date

January 13, 2020

Conditions

Episodic Migraine

Interventions

BIOLOGICAL

Erenumab

70 mg/mL pre-filled syringe administered subcutaneously

OTHER

Placebo

Matching placebo in pre-filled syringe administered subcutaneously

Trial Locations (81)

1000

Novartis Investigative Site, Manila

1012

Novartis Investigative Site, Manila

1061

Novartis Investigative Site, Buenos Aires

1102

Novartis Investigative Site, Quezon City

1605

Novartis Investigative Site, Pasig

5001

Novartis Investigative Site, Córdoba

6301

Novartis Investigative Site, Beirut

10330

Novartis Investigative Site, Bangkok

10400

Novartis Investigative Site, Bangkok

10449

Novartis Investigative Site, Taipei

11217

Novartis Investigative Site, Taipei

11765

Novartis Investigative Site, Gyeonggi-do

13700

Novartis Investigative Site, Seberang Jaya

18450

Novartis Investigative Site, Hwaseong-si

22332

Novartis Investigative Site, Incheon

31203

Novartis Investigative Site, Chihuahua City

33305

Novartis Investigative Site, Taoyuan District

35015

Novartis Investigative Site, Daejeon

40002

Novartis Investigative Site, Khon Kaen

40447

Novartis Investigative Site, Taichung

44130

Novartis Investigative Site, Guadalajara

44610

Novartis Investigative Site, Guadalajara

47000

Novartis Investigative Site, Sungai Buloh

47392

Novartis Investigative Site, Busan

50200

Novartis Investigative Site, Chiang Mai

50586

Novartis Investigative Site, Kuala Lumpur

56000

Novartis Investigative Site, Kuala Lumpur

59100

Novartis Investigative Site, Kuala Lumpur

60002

Novartis Investigative Site, Chiayi City

61469

Novartis Investigative Site, Gwangju

64060

Novartis Investigative Site, Monterrey

71004

Novartis Investigative Site, Tainan City

100000

Novartis Investigative Site, Hanoi

110002

Novartis Investigative Site, New Delhi

110029

Novartis Investigative Site, New Delhi

141001

Novartis Investigative Site, Ludhiana

166378

Novartis Investigative Site, Beirut

169608

Novartis Investigative Site, Singapore

226014

Novartis Investigative Site, Lucknow

248001

Novartis Investigative Site, Dehradun

308433

Novartis Investigative Site, Singapore

382428

Novartis Investigative Site, Ahmedabad

400008

Novartis Investigative Site, Mumbai

400016

Novartis Investigative Site, Mumbai

401107

Novartis Investigative Site, Mumbai

411004

Novartis Investigative Site, Pune

422005

Novartis Investigative Site, Nashik

500082

Novartis Investigative Site, Hyderabad

560054

Novartis Investigative Site, Bangalore

560060

Novartis Investigative Site, Bangalore

570001

Novartis Investigative Site, Mysore

590010

Novartis Investigative Site, Belagavi

600100

Novartis Investigative Site, Chennai

673004

Novartis Investigative Site, Kozhikode

682027

Novartis Investigative Site, Kochi

695011

Novartis Investigative Site, Thiruvananthapuram

700000

Novartis Investigative Site, Ho Chi Minh City

700017

Novartis Investigative Site, Kolkata

700068

Novartis Investigative Site, Kolkata

1503201002

Novartis Investigative Site, El Chouf

C1056ABJ

Novartis Investigative Site, CABA

C1181ACH

Novartis Investigative Site, CABA

C1428AQK

Novartis Investigative Site, CABA

C1012AAR

Novartis Investigative Site, Buenos Aires

C1128AAF

Novartis Investigative Site, Ciudad Autonoma de Bs As

522 001

Novartis Investigative Site, Guntur

682 026

Novartis Investigative Site, Kochi

400 012

Novartis Investigative Site, Nagpur

422 005

Novartis Investigative Site, Nashik

110 060

Novartis Investigative Site, New Delhi

1107 2020

Novartis Investigative Site, Beirut

Unknown

Novartis Investigative Site, Beirut

Novartis Investigative Site, Taichung County

Novartis Investigative Site, Tainan City